Michael Petusky Stock Analyst Profile - Barrington Research Research Coverage - Stocknear

Michael Petusky

Stock Analyst at Barrington Research

(3.43)
# 2686
Out of 5,478 analysts
214
Total ratings
Success rate
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
VRME VerifyMe
Maintains: Outperform
2 2
0.82 82.93% 10 Aug 14, 2025
SRDX Surmodics
Reiterates: Market Perform
n/a
n/a n/a 7 Aug 11, 2025
XRAY Dentsply Sirona
Maintains: Outperform
21 18
13.53 33.04% 21 Aug 8, 2025
USPH US Physical Therapy
Maintains: Outperform
98 103
80.26 28.33% 24 Aug 8, 2025
HAE Haemonetics
Maintains: Outperform
95 86
52.2 64.75% 25 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
95
92.29 2.94% 11 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
86 78
69.01 13.03% 15 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
103 103
85.53 20.43% 21 Jul 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
19 15
8.67 73.01% 18 Jul 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
38 38
28.48 33.43% 16 Jul 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
16
14.91 7.31% 1 Jun 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 15 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
3 3
1.4 60.71% 12 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 Aug 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 12
8.76 36.99% 6 Oct 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Jul 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
n/a n/a 1 Jun 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Dec 18, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Aug 3, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Aug 11, 2016